| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/03/2003 | US20030064085 Cosmetic or dermatological composition comprising a combination of an elastase inhibitor of the N-acylaminoamide family and at least one myorelaxing agent |
| 04/03/2003 | US20030064069 Specific binding members for TGFbeta1 |
| 04/03/2003 | US20030064063 For prophylaxis of type I hypersensitivity disease in a subject receiving immunotherapy |
| 04/03/2003 | US20030064048 Topically applying to skin formulation comprising one or more compounds derived from one or more of the botanical families leguminosae, solanaceae, gramineae and cucurbitaceae for effecting changes in mammalian hair appearance, hair growth |
| 04/03/2003 | CA2464436A1 Method and topical formulation for treating skin conditions associated with aging |
| 04/03/2003 | CA2461709A1 Small organic molecule regulators of cell proliferation |
| 04/03/2003 | CA2461666A1 Combination therapies for immune mediated diseases |
| 04/03/2003 | CA2461504A1 Polymers with structure-defined functions |
| 04/03/2003 | CA2461372A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | CA2461346A1 Anti-inflammatory dermocosmetologic composition in particular for treating acne and seborrheic dermatitis |
| 04/03/2003 | CA2461095A1 Process for making substituted pyrazoles |
| 04/03/2003 | CA2460953A1 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | CA2459943A1 Androstanes as androgen receptor modulators |
| 04/03/2003 | CA2458279A1 Modulation of vitamin storage |
| 04/03/2003 | CA2455989A1 Neuroprotective treatment methods using selective inos inhibitors |
| 04/02/2003 | EP1298211A2 Polynucleotide segment of HPV16 Genome |
| 04/02/2003 | EP1298206A1 Use of the Factor VII-activating protease for prevention and therapy of vaso-proliferative disorders |
| 04/02/2003 | EP1297837A1 Remedies for allergic diseases and process for producing the same |
| 04/02/2003 | EP1297833A1 Indole carboxylic acids as thyroid receptor ligands |
| 04/02/2003 | EP1297832A2 Composition and methods for treating psoriasis |
| 04/02/2003 | EP1297831A2 Compositions and methods for epidermal chemexfoliation |
| 04/02/2003 | EP1297180A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 04/02/2003 | EP1297142A2 Dual specificity antibodies and methods of making and using |
| 04/02/2003 | EP1297137A2 Gp286 nucleic acids and polypeptides |
| 04/02/2003 | EP1297129A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 04/02/2003 | EP1297107A2 Intervertebral disc |
| 04/02/2003 | EP1297014A2 Transporters and ion channels |
| 04/02/2003 | EP1297012A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 04/02/2003 | EP1297007A2 Mammalian protein phosphatases |
| 04/02/2003 | EP1296996A1 Purine derivatives |
| 04/02/2003 | EP1296985A2 Heteropolycyclic inhibitors |
| 04/02/2003 | EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 04/02/2003 | EP1296956A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 04/02/2003 | EP1296954A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia |
| 04/02/2003 | EP1296951A1 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl- [2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 04/02/2003 | EP1296949A2 Piperidine amides as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 04/02/2003 | EP1296943A1 Amino acid derivatives and their use as medicines |
| 04/02/2003 | EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/02/2003 | EP1296934A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 04/02/2003 | EP1296929A2 Modified forms of pharmacologically active agents and uses therefor |
| 04/02/2003 | EP1296924A1 Method for producing a non-fatty softener based on wax-esters |
| 04/02/2003 | EP1296923A2 Aspirin-triggered lipid mediators |
| 04/02/2003 | EP1296709A1 Solubilised protein vaccines |
| 04/02/2003 | EP1296702A1 Neuroprotective peptides |
| 04/02/2003 | EP1296701A1 Use of grifola frondosa fungus extracts |
| 04/02/2003 | EP1296699A1 Therapeutic agents - iii |
| 04/02/2003 | EP1296698A1 Therapeutic agents - ii |
| 04/02/2003 | EP1296697A1 Therapeutic agents - i |
| 04/02/2003 | EP1296695A2 Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair |
| 04/02/2003 | EP1296692A1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/02/2003 | EP1296670A1 Therapeutic combinations of fatty acids |
| 04/02/2003 | EP1296669A1 COMBINATION PREPARATION CONSISTING OF $g(V)-3-FATTY ACIDS AND OF CONJUGATED LINOLEIC ACIDS FOR TREATING IMMUNOLOGICALLY ORIENTED CLINICAL SIGNS |
| 04/02/2003 | EP1296667A2 Use of an aluminium and ethylenediamine-tetraacetic complex for preventing and/or treating urticaria |
| 04/02/2003 | EP1296652A1 Topical pharmaceutical formulations and methods of treatment |
| 04/02/2003 | EP1296650A2 Methods and compositions for treating pain of the mucous membrane |
| 04/02/2003 | EP1296646A2 Oral pharmaceutical compositions containing terbinafine |
| 04/02/2003 | EP1296644A2 Systems and methods for treating a mucosal surface |
| 04/02/2003 | EP1296639A1 Cosmetic and pharmaceutical compositions and methods using green-light emitting materials |
| 04/02/2003 | EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 04/02/2003 | EP1246627A4 Polyanhydrides with biologically active degradation products |
| 04/02/2003 | EP1226143B1 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors |
| 04/02/2003 | EP1211942B1 Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution |
| 04/02/2003 | EP1208100B1 Selective antagonists of a2b adenosine receptors |
| 04/02/2003 | EP1135126A4 Myt1 kinase inhibitors |
| 04/02/2003 | EP1114051B1 INHIBITORS OF p38 |
| 04/02/2003 | EP1083886B1 Drug delivery system comprising a tightly compacted solid medicament stock |
| 04/02/2003 | EP1030842B1 Metalloproteinase inhibitors |
| 04/02/2003 | EP0975319B1 Skin care compositions containing an acid and a retinoid |
| 04/02/2003 | EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 04/02/2003 | EP0927053B1 Fragmented polymeric hydrogels for adhesion prevention and their preparation |
| 04/02/2003 | EP0873295B1 Dimer-selective rxr modulators and methods for their use |
| 04/02/2003 | CN1407993A Gene recombinant antibody and its fragment |
| 04/02/2003 | CN1407992A Process for producing functional silk fibroin and utilization of the same |
| 04/02/2003 | CN1407990A C-aryl glucoside sgltz inhibitors |
| 04/02/2003 | CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor |
| 04/02/2003 | CN1407983A Tert-butyl-(7-methyl-imidazo [1,2-A] pyridine-3-yl)-amine derivatives |
| 04/02/2003 | CN1407978A Polyhydroxystilbenes and stibene oxides as antisoriatic agents and protein kinase inhibitors |
| 04/02/2003 | CN1407902A Remedies for intractable wound |
| 04/02/2003 | CN1407890A Treatment of psoriasis |
| 04/02/2003 | CN1406633A Scarless composite biological material containing hyaluronic acid |
| 04/02/2003 | CN1406629A Vaccin of heterogenous blood vessel endothetial cell growth factor and preparing process thereof |
| 04/02/2003 | CN1406621A Medicines for treating psoriasis |
| 04/02/2003 | CN1406615A Medicine against for beriberi and sore and boil |
| 04/02/2003 | CN1406608A Disinfecting bactericidal agent for treating freckle and preparation |
| 04/02/2003 | CN1406607A Disinfecting bactericida agent and preparation thereof |
| 04/02/2003 | CN1406605A Oral liquid for quick action treating acne and preparation thereof |
| 04/02/2003 | CN1406596A Priscription of external used burn and scald and preparing process thereof |
| 04/02/2003 | CN1406489A Collagen-DNA-Ag composition with bacteriostatic function and preparation thereof |
| 04/02/2003 | CN1104412C Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect |
| 04/02/2003 | CN1104244C Use of physiologically acceptable vanadium compounds, salts and compelxes |
| 04/01/2003 | US6541670 Antiinflammatory agents |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction |
| 04/01/2003 | US6541629 Enzyme inhibitors |
| 04/01/2003 | US6541605 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |